257 results on '"Gondi, P"'
Search Results
2. Enhancing Student Career Readiness through Skills Infusion
- Author
-
Hua, David M., Davison, Christopher B., and Gondi, Vamsi K.
- Abstract
The rising cost of higher education has led parents, employers, and politicians to question the need for a college degree. Skills Infusion is a professional development program in which faculty review a course they teach to identify the career readiness competencies defined by the National Association of Colleges and Employers (NACE). The NACE competencies are skills that are expected by employers across all sectors of the economy. In addition to describing the Skills Infusion program, a description of how an information technology undergraduate program is expanding on the program to incorporate skills mapping to provide further evidence of accountability in higher education.
- Published
- 2022
3. IoT Education Using Learning Kits of IoT Devices
- Author
-
Bajracharya, Biju, Gondi, Vamsi, and Hua, David
- Abstract
The rapid growth of inexpensive and easily accessible communicating devices embedded into new or existing physical devices transform them into the intelligent devices that comprise the Internet of Things (IoT). The increasing use of these devices has attracted attention from various sectors, including consumer market, business, industry, health, government, education, research, and many others. In educational sectors, many institutions are exploring the advanced digital infrastructure applications to improve the learning and teaching abilities of the difficult subjects of Science, Technology, Engineering, and Mathematics (STEM). IoT devices in the classroom or in laboratory activities can enhance the learning process with innovative ideas to increase student motivation in much faster and effective ways. In addition to using IoT to enhance the educational process, IoT serves as an important topic of study. IoT education consists of diverse components including hardware, software, programming, and electronics. How IoT is incorporated into the curriculum is based on the programmatic objectives. For non-engineers, non-coders, and many others, IoT courses need to be designed and delivered in a different way than would be done with engineering, engineering technology, and computer science majors. This paper will discuss the use of widely available educational IoT kits that could be used for beginners or non-majors.
- Published
- 2021
4. Incidence of post-implant ventricular arrhythmias in patients with HeartMate 3 left ventricular assist devices
- Author
-
Larson, John, Gondi, Keerthi, Deshmukh, Amrish, Cascino, Thomas M., Ghannam, Michael, Bogun, Frank, and Liang, Jackson J.
- Published
- 2024
- Full Text
- View/download PDF
5. Transition to Amazon AWS from a Traditional Cluster-Based Information Technology Classroom
- Author
-
Gondi, Vamsi, Hua, David, and Bajracharya, Biju Raja
- Abstract
In the age of COVID-19, traditional teaching techniques are under scrutiny. Most concepts and labs in the area of information technology are intended to be taught face-to-face in labs using clusters and networking infrastructure. Simulation software's such as uCertify, Pearson online, etc.., are good alternative, but are not always a viable solution. Simulation software is used primarily to understand, remember, and apply the concepts rather than analyze evaluate and create the content. Due to unforeseen conditions during March 2020, educational institutions were required to shut down. In the middle of the semester, instructors had to determine how to complete the labs and final projects which are crucial to accomplishing the intended learning outcomes of their courses. A chosen alternative was to use Amazon AWS as a cloud platform to host the labs and projects. It was initially a challenge as students had not had the opportunity to learn how to work with AWS in advance. Training sessions were provided to help them understand how to deploy and connect virtual servers in AWS to build a virtual private cloud. Prior to the pandemic, students developed and deployed their labs and projects on a departmental cluster which was on-premise at the university. With AWS, it was challenging to design an architecture to host 19 services offered as a part of the project requirements for an organization network. This paper presents the scope of this project; the intended outcomes of the project, how students were able to implement the project requirements in the AWS environment; the intended learning outcomes; and the results of student surveys to assess the learning outcome of using AWS and traditional cluster.
- Published
- 2021
6. An Overlooked Medication-Induced Celiac Flare Complicating Treatment of Osteoporosis
- Author
-
Van Phan, MD, John Aurora, Jr., PharmD, BCACP, CDCES, Suma Gondi, MD, and Lisa Ceglia, MD, MS
- Subjects
celiac disease ,osteoporosis ,hyperparathyroidism ,clinical pharmacist ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
Background/Objective: Celiac disease, an immune reaction to gluten causing nutrient malabsorption, and long-term glucocorticoid therapy adversely affect bone metabolism and increase fracture risk. Case Report: A patient with long-standing celiac disease on a strict gluten-free diet and long-term glucocorticoid therapy status post kidney transplant for Sjögren syndrome–induced interstitial nephritis presented for management of osteoporosis. Initial evaluation was notable for secondary hyperparathyroidism, which resolved after switching to a gluten-free calcium citrate supplement. Given normal serum total alkaline phosphatase (ALP) and parathyroid hormone (PTH), she began treatment of osteoporosis with abaloparatide. Two months later, she reported abrupt onset of diarrhea with significant weight loss. Biochemical investigation revealed a threefold increase in serum ALP level. As a precaution, abaloparatide was suspended, yet symptoms persisted with elevated ALP and PTH levels. Endoscopy revealed a celiac flare. The clinic-based pharmacist found that her pharmacy had inadvertently dispensed prednisone tablets containing wheat starch. A switch to a gluten-free formulation led to rapid resolution of the diarrhea with weight regain. Serum ALP and PTH levels normalized, and abaloparatide was resumed without biochemical abnormalities. Discussion: An unintended switch to a gluten-containing prednisone formulation resulted in uncontrolled celiac disease causing calcium malabsorption, secondary hyperparathyroidism, elevated ALP levels, and an interruption in osteoporosis therapy. Common supplements and drugs can be a hidden source of gluten. Collaboration with a clinic-based pharmacist enhances the detection and prevention of medication-induced adverse reactions. Conclusion: This case highlights the importance of a careful review of gluten-containing medications and supplements in patients with celiac disease.
- Published
- 2024
- Full Text
- View/download PDF
7. Achieving Surgical, Obstetric, Trauma, and Anesthesia (SOTA) care for all in South Asia
- Author
-
Siddhesh Zadey, Shirish Rao, Isha Gondi, Natalie Sheneman, Chaitrali Patil, Anveshi Nayan, Himanshu Iyer, Arti Raj Kumar, Arun Prasad, G. Allen Finley, Chellapuram Raja Krishna Prasad, Chintamani, Dhananjaya Sharma, Dhruva Ghosh, Gnanaraj Jesudian, Irum Fatima, Jogi Pattisapu, Justin Sangwook Ko, Lovenish Bains, Mashal Shah, Mohammed Shadrul Alam, Narmada Hadigal, Naveen Malhotra, Nilmini Wijesuriya, Prateek Shukla, Sadaf Khan, Sunil Pandya, Tariq Khan, Tashi Tenzin, Venkat Raja Hadiga, and Daniel Peterson
- Subjects
global surgery ,SOTA care ,South Asia ,priorities ,health planning ,LMICs ,Public aspects of medicine ,RA1-1270 - Abstract
South Asia is a demographically crucial, economically aspiring, and socio-culturally diverse region in the world. The region contributes to a large burden of surgically-treatable disease conditions. A large number of people in South Asia cannot access safe and affordable surgical, obstetric, trauma, and anesthesia (SOTA) care when in need. Yet, attention to the region in Global Surgery and Global Health is limited. Here, we assess the status of SOTA care in South Asia. We summarize the evidence on SOTA care indicators and planning. Region-wide, as well as country-specific challenges are highlighted. We also discuss potential directions—initiatives and innovations—toward addressing these challenges. Local partnerships, sustained research and advocacy efforts, and politics can be aligned with evidence-based policymaking and health planning to achieve equitable SOTA care access in the South Asian region under the South Asian Association for Regional Cooperation (SAARC).
- Published
- 2024
- Full Text
- View/download PDF
8. Professional Backgrounds of Board Members at Top-Ranked US Hospitals
- Author
-
Gondi, Suhas, Kishore, Sanjay, and McWilliams, J. Michael
- Published
- 2023
- Full Text
- View/download PDF
9. Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience
- Author
-
Larson, John, Gondi, Keerthi, Chou, Andrew, Deshmukh, Amrish, Cascino, Thomas M., Ghannam, Michael, Judge, Erin C., Latchamsetty, Rakesh, Jongnarangsin, Krit, Aaronson, Keith D., Pagani, Francis D., Bogun, Frank, and Liang, Jackson J.
- Published
- 2023
- Full Text
- View/download PDF
10. Cardiac Rhabdomyomas as a Cause of Neonatal Arrhythmias
- Author
-
Gondi, Bhoojata and Rama Rao, P. V.
- Published
- 2024
- Full Text
- View/download PDF
11. Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based Approach
- Author
-
Du Wang, Huaizhi Geng, Vinai Gondi, Nancy Y. Lee, Christina I. Tsien, Ping Xia, Thomas L. Chenevert, Jeff M. Michalski, Mark R. Gilbert, Quynh-Thu Le, Antonio M. Omuro, Kuo Men, Kenneth D. Aldape, Yue Cao, Ashok Srinivasan, Igor J. Barani, Sean Sachdev, Jiayi Huang, Serah Choi, Wenyin Shi, James D. Battiste, Zabi Wardak, Michael D. Chan, Minesh P. Mehta, and Ying Xiao
- Subjects
radiotherapy ,knowledge-based planning ,brain and head/neck cancers ,clinical trial quality assurance ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
The quality of radiation therapy (RT) treatment plans directly affects the outcomes of clinical trials. KBP solutions have been utilized in RT plan quality assurance (QA). In this study, we evaluated the quality of RT plans for brain and head/neck cancers enrolled in multi-institutional clinical trials utilizing a KBP approach. The evaluation was conducted on 203 glioblastoma (GBM) patients enrolled in NRG-BN001 and 70 nasopharyngeal carcinoma (NPC) patients enrolled in NRG-HN001. For each trial, fifty high-quality photon plans were utilized to build a KBP photon model. A KBP proton model was generated using intensity-modulated proton therapy (IMPT) plans generated on 50 patients originally treated with photon RT. These models were then applied to generate KBP plans for the remaining patients, which were compared against the submitted plans for quality evaluation, including in terms of protocol compliance, target coverage, and organ-at-risk (OAR) doses. RT plans generated by the KBP models were demonstrated to have superior quality compared to the submitted plans. KBP IMPT plans can decrease the variation of proton plan quality and could possibly be used as a tool for developing improved plans in the future. Additionally, the KBP tool proved to be an effective instrument for RT plan QA in multi-center clinical trials.
- Published
- 2024
- Full Text
- View/download PDF
12. The Multifaceted Role of miR-21 in Pancreatic Cancers
- Author
-
Clare Chen, Lusine Demirkhanyan, and Christopher S. Gondi
- Subjects
miR-21 ,pancreatic ductal adenocarcinoma ,small non-coding RNA ,proliferation ,epithelial–mesenchymal transition (EMT) ,Cytology ,QH573-671 - Abstract
With the lack of specific signs and symptoms, pancreatic ductal adenocarcinoma (PDAC) is often diagnosed at late metastatic stages, resulting in poor survival outcomes. Among various biomarkers, microRNA-21 (miR-21), a small non-coding RNA, is highly expressed in PDAC. By inhibiting regulatory proteins at the 3′ untranslated regions (UTR), miR-21 holds significant roles in PDAC cell proliferation, epithelial–mesenchymal transition, angiogenesis, as well as cancer invasion, metastasis, and resistance therapy. We conducted a systematic search across major databases for articles on miR-21 and pancreatic cancer mainly published within the last decade, focusing on their diagnostic, prognostic, therapeutic, and biological roles. This rigorous approach ensured a comprehensive review of miR-21’s multifaceted role in pancreatic cancers. In this review, we explore the current understandings and future directions regarding the regulation, diagnostic, prognostic, and therapeutic potential of targeting miR-21 in PDAC. This exhaustive review discusses the involvement of miR-21 in proliferation, epithelial–mesenchymal transition (EMT), apoptosis modulation, angiogenesis, and its role in therapy resistance. Also discussed in the review is the interplay between various molecular pathways that contribute to tumor progression, with specific reference to pancreatic ductal adenocarcinoma.
- Published
- 2024
- Full Text
- View/download PDF
13. Federal Election Campaign Spending Among Political Action Committees Affiliated with Physician Society Organizations
- Author
-
Khetpal, Vishal, Gondi, Suhas, Andrea, Sarah B., and Song, Zirui
- Published
- 2023
- Full Text
- View/download PDF
14. Regulatory approval of clinical trials: is it time to reinvent the wheel?
- Author
-
Mansoor Saleh, Karishma Sharma, Aisleen Shamshudin, Innocent Obayo, Stacey Gondi, and Noureen Karimi
- Subjects
Medicine (General) ,R5-920 ,Infectious and parasitic diseases ,RC109-216 - Abstract
Less than 1% of all clinical trials are conducted in Africa. In 2019, only six of 26 oncology clinical trials conducted in Africa were conducted in countries with subjects of African ancestry. There are multiple barriers that hinder the conduct of cancer clinical trials in Africa. Time to trial activation (TTA) is the administrative and regulatory process required before a study can be activated—an important metric and often a major barrier for site selection. In Kenya, TTA involves review by Institutional Review Board (IRB), Pharmacy and Poisons Board, National Commission for Science, Technology and Innovation and Ministry of Health, all in a sequential fashion. We performed a prospective review of TTA for all clinical trials initiated and began enrolment at the Aga Khan University-Clinical Research Unit between June 2020 and November 2022. TTA was defined as total time from submission of study documents (to regulatory bodies) to site activation by the sponsor. A total of 12 studies were submitted for regulatory review. Eleven (nine industry sponsored and two investigator initiated) were approved for activation. Three were COVID-19-related studies and eight were non-COVID-19-related studies. Mean TTA for COVID-related studies was 80 days (range 40–120). Mean TTA for non-COVID-related studies was 259 days (range 190–399). This TTA difference was statistically significant (p=0.02). TTA remains a significant barrier to the efficient regulatory approval of and subsequent conduct of clinical trials in Africa. COVID-19 pandemic revealed that parallel processing and expedited review of clinical trials allows efficient TTA without compromising human subject safety or data integrity. These lessons need to be applied to all clinical trials in order for African sites to become competitive and contribute data from African patients to global knowledge.
- Published
- 2024
- Full Text
- View/download PDF
15. CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens
- Author
-
Saha, Ujjayani, Gondi, Rashmi, Patil, Amrita, and Saroj, Sunil D.
- Published
- 2023
- Full Text
- View/download PDF
16. Characterization and Pathogenicity of Causing Black Root Rot and Identification of Novel Sources of Resistance in Mulberry Collections
- Author
-
Belaghihalli N. Gnanesh, Gondi S. Arunakumar, Avuthu Tejaswi, M. Supriya, Haniyambadi B. Manojkumar, and Suvala Shalini Devi
- Subjects
black root rot ,mulberry ,pathogenicity ,resistance ,Plant culture ,SB1-1110 - Abstract
Black root rot (BRR) caused by Lasiodiplodia theobromae is an alarming disease of mulberry that causes tremendous economic losses to sericulture farmers in India and China. Successful control of this disease can be attained by screening germplasm and identifying resistant sources. Seventy four diseased root samples were collected from farmer’s fields belonging to four major mulberry growing states of South India. Based on morpho-cultural and scanning electron microscopy studies, 57 fungal isolates were characterized and identified as L. theobromae. Phylogenetic analysis of concatenated internal transcribed spacer and β-tubulin sequences revealed variation of the representative 20 isolates of L. theobromae. Following the root dip method of inoculation, pathogenicity studies on susceptible mulberry genotypes (Victory-1 and Thailand male) recognized the virulent isolate MRR-142. Accordingly, MRR-142 isolate was used to evaluate resistance on a set of 45 diverse mulberry accessions. In the repeated experiments, the mulberry accession ME-0168 which is an Indonesian origin belonging to Morus latifolia was found to be highly resistant consistently against BRR. Eight accessions (G2, ME-0006, ME-0011, ME-0093, MI-0006, MI-0291, MI-0489, and MI-0501) were found to be resistant. These promising resistant resources may be exploited in mulberry breeding for developing BRR resistant varieties and to develop mapping populations which successively helps in the identification of molecular markers associated with BRR.
- Published
- 2022
- Full Text
- View/download PDF
17. Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003
- Author
-
Brady S. Laughlin, MD, Cameron S. Thorpe, MD, Todd A. DeWees, PhD, Molly M. Voss, BA, John H. Chang, MD, William F. Hartsell, MD, Christopher C. Sinesi, MD, Jean-Claude M. Rwigema, MD, Sameer R. Keole, MD, Vinai Gondi, MD, and Carlos E. Vargas, MD
- Subjects
Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Purpose: Our objective was to report the quality of life (QoL) analysis and toxicity in patients with intermediate-risk prostate cancer treated with or without androgen deprivation therapy (ADT) in Proton Collaborative Group (PCG) GU003. Methods and Materials: Between 2012 and 2019, patients with intermediate-risk prostate cancer were enrolled. Patients were randomized to receive moderately hypofractionated proton beam therapy (PBT) to 70 Gy relative biologic effectiveness in 28 fractions to the prostate with or without 6 months of ADT. Expanded Prostate Cancer Index Composite, Short-Form 12, and the American Urological Association Symptom Index instruments were given at baseline and 3, 6, 12, 18, and 24 months after PBT. Toxicities were assessed according to Common Terminology Criteria for Adverse Events (version 4). Results: One hundred ten patients were randomized to PBT either with 6 months of ADT (n = 55) or without ADT (n = 55). The median follow-up was 32.4 months (range, 5.5-84.6). On average, 101 out of 110 (92%) patients filled out baseline QoL and patient-reported outcome surveys. The compliance was 84%, 82%, 64%, and 42% at 3, 6, 12, and 24 months, respectively. Baseline median American Urological Association Symptom Index was comparable between arms (6 [11%] ADT vs 5 [9%] no ADT, P = .359). Acute and late grade 2+ genitourinary and gastrointestinal toxicity were similar between arms. The ADT arm experienced a QoL decline of mean scores in the sexual (–16.1, P < .001) and hormonal (–6.3, P < .001) domains, with the largest time-specific hormonal differences at 3 (–13.8, P < .001) and 6 (–11.2, P < .001) months. The hormonal QoL domain returned to baseline 6 months after therapy. There was a trend to baseline in sexual function 6 months after completion of ADT. Conclusions: After 6 months of ADT, sexual and hormonal domains returned to baseline 6 months after completion of treatment for men with intermediate-risk prostate cancer.
- Published
- 2023
- Full Text
- View/download PDF
18. Evidence and Efficacy in the Era of Digital Care
- Author
-
Gondi, Suhas, Powers, Brian W., and Shrank, William H.
- Published
- 2022
- Full Text
- View/download PDF
19. Synthesis of Diverse N‑Trifluoromethyl Pyrazoles by Trapping of Transiently-Generated Trifluoromethylhydrazine.
- Author
-
Li, Bao, Xie, Fenglei, Zhang, Rui, Wang, Yaoyi, Gondi, Vijaya B., and Hale, Christopher R. H.
- Published
- 2024
- Full Text
- View/download PDF
20. Dose-escalated accelerated hypofractionation for elderly or frail patients with a newly diagnosed glioblastoma
- Author
-
Perlow, Haley K., Yaney, Alexander, Yang, Michael, Klamer, Brett, Matsui, Jennifer, Raval, Raju R., Blakaj, Dukagjin M., Arnett, Andrea, Beyer, Sasha, Elder, James B., Ammirati, Mario, Lonser, Russell, Hardesty, Douglas, Ong, Shirley, Giglio, Pierre, Pillainayagam, Clement, Goranovich, Justin, Grecula, John, Chakravarti, Arnab, Gondi, Vinai, Brown, Paul D., and Palmer, Joshua D.
- Published
- 2022
- Full Text
- View/download PDF
21. Evaluation of bond durability, surface morphology, and remineralization at the adhesive interface with dentin bonding agents modified with silica-doped nanohydroxyapatite
- Author
-
Prasanthi Gonapa, Girija S Sajjan, Arun Bhupathi, Uday K Podugu, Suvarna Sundar, Durgabhavani Gondi, and R Tejasree Rathod
- Subjects
dentin bonding agents ,microshear bond strength ,nanohydroxyapatite ,remineralization ,silica-doped nanohydroxyapatite ,Dentistry ,RK1-715 - Abstract
Objectives: To compare and evaluate the bond durability, surface morphology, and remineralization of the adhesive layer with newer adhesive systems modified with novel bioactive nanoparticles. Methodology: Bonding agents evaluated in this study include (a) Conventional dentin bonding agent (CN-DBA) (b) Nanohydroxyapatite (nanoHAP) incorporated dentin bonding agent (NH DBA); (c) Silica doped nanohydroxyapatite (Si nanoHAP) incorporated dentin bonding agent (Si NH DBA). A total of 104 human dentin discs (5 mm × 5 mm × 2 mm) were sectioned. Elemental analysis (Ca/P ratio) and surface morphology of the adhesive layer with different dentin adhesives were evaluated under scanning electron microscopy with energy-dispersive X-ray analysis after speculated storage time of 1 day and 6 months. Microshear bond strength of adhesive restorations with different dentin adhesives was evaluated under universal testing machine and fractographic analysis under scanning electron microscope after speculated storage time of 1 day and 6 months. The results were analyzed using analysis of variance and post hoc analysis. Results: Si-NH-DBA showed highest mean microshear bond strength for both 1 day and 6 months, which was significantly higher compared to conventional nanofilled dentin bonding agent (CN-DBA) and NH-DBA. Si-NH-DBA group showed only 10% reduction in bond strength after 6 months, which was less compared to that of other groups. Similarly, Si-NH-DBA showed higher remineralization with stellate-shaped crystals at the adhesive layer after 6 months with hydrolytic resistant hybrid layer, compared to CN-DBA and NH-DBA. Conclusion: Silica-doped nanohydroxyapatite proved its efficiency on bond stability, remineralization, and hydrolytic resistance when incorporated into dentin bonding agents because of its bioactivity and carbonate-containing apatite-forming ability.
- Published
- 2022
- Full Text
- View/download PDF
22. Correction: The Story of #GetMePPE and GetUsPPE.org to Mobilize Health Care Response to COVID-19 : Rapidly Deploying Digital Tools for Better Health Care
- Author
-
Shuhan He, Ayotomiwa Ojo, Adam L Beckman, Suhas Gondi, Megan Ranney, Marian Betz, Jeremy S Faust, Esther Choo, Dara Kass, and Ali S Raja
- Subjects
Computer applications to medicine. Medical informatics ,R858-859.7 ,Public aspects of medicine ,RA1-1270 - Published
- 2023
- Full Text
- View/download PDF
23. A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas
- Author
-
Dixit, Karan S, Sachdev, Sean, Amidei, Christina, Kumthekar, Priya, Kruser, Tim J, Gondi, Vinai, Grimm, Sean, Lukas, Rimas V, Nicholas, Martin Kelly, Chmura, Steven J, Fought, Angela J, Mehta, Minesh, and Raizer, Jeffrey J
- Published
- 2021
- Full Text
- View/download PDF
24. Association of Pretreatment Hippocampal Volume With Neurocognitive Function in Patients Treated With Hippocampal Avoidance Whole Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology/RTOG 0933
- Author
-
Christopher D. Abraham, MD, Stephanie L. Pugh, PhD, Joseph A. Bovi, MD, Vinai Gondi, MD, Minesh P. Mehta, MD, Tammie Benzinger, MD, Christopher J. Owen, MS, Simon S. Lo, MD, Vijayananda Kundapur, MD, Paul D. Brown, MD, Alexander Y. Sun, MD, Steven P. Howard, MD, Albert S. DeNittis, MD, Clifford G. Robinson, MD, and Lisa A. Kachnic, MD
- Subjects
Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Purpose: Hippocampal volume (HV) is an established predicting factor for neurocognitive function (NCF) in neurodegenerative disease. Whether the same phenomenon exists with hippocampal-avoidant whole brain radiation therapy is not known; therefore, we assessed the association of baseline HV with NCF among patients enrolled on RTOG 0933. Methods and Materials: Hippocampal volume and total brain volume were calculated from the radiation therapy plan. Hippocampal volume was correlated with baseline and 4-month NCF scores (Hopkins Verbal Learning Test–Revised [HVLT-R] Total Recall [TR], Immediate Recognition, and Delayed Recall [DR]) using Pearson correlation. Deterioration in NCF was defined per the primary endpoint of RTOG 0933(mean 4-month relative decline in HVLT-R DR). Comparisons between patients with deteriorated and nondeteriorated NCF were made using the Wilcoxon test. Results: Forty-two patients were evaluable. The median age was 56.5 years (range, 28-83 years), and 81% had a class II recursive partitioning analysis. The median total, right, and left HVs were 5.4 cm3 (range, 1.9-7.4 cm3), 2.8 cm3 (range, 0.9-4.0 cm3), and 2.7 cm3 (range, 1.0-3.7 cm3), respectively. The median total brain volume was 1343 cm3 (range, 1120.5-1738.8 cm3). For all measures of corrected HV, increasing HV was associated with higher baseline HVLT-R TR and DR scores (ρ: range, 0.35-0.40; P-value range, .009-.024) and 4-month TR and DR scores (ρ: range, 0.29-0.40; P-value range, .009-.04), with the exception of right HV and 4-month DR scores (ρ: 0.29; P = .059). There was no significant association between HV and NCF change between baseline and 4 months. Fourteen patients (33.3%) developed NCF deterioration per the primary endpoint of RTOG 0933. There was no significant difference in HV between patients with deteriorated and nondeteriorated NCF, although in all instances, patients with deteriorated NCF had numerically lower HV. Conclusions: Larger HV was positively associated with improved performance on baseline and 4-month HVLT-R TR and DR scores in patients with brain metastases undergoing hippocampal-avoidant whole brain radiation therapy but was not associated with a change in NCF.
- Published
- 2022
- Full Text
- View/download PDF
25. Investing in the health workforce in Kenya: trends in size, composition and distribution from a descriptive health labour market analysis
- Author
-
Juliet Nabyonga-Orem, James Avoka Asamani, Annah Wamae, Adam Ahmat, Zeinab Gura, Pascal Zurn, Sunny C Okoroafor, Brendan Kwesiga, Julius Ogato, Joel Gondi, Nakato Jumba, Teresa Ogumbo, Maureen Monyoncho, Mutile Wanyee, Meldah Angir, Mona Ahmed Almudhwahi, and Chagina Evalyne
- Subjects
Medicine (General) ,R5-920 ,Infectious and parasitic diseases ,RC109-216 - Published
- 2022
- Full Text
- View/download PDF
26. Modulation of Mitochondrial Metabolic Parameters and Antioxidant Enzymes in Healthy and Glaucomatous Trabecular Meshwork Cells with Hybrid Small Molecule SA-2
- Author
-
Charles E. Amankwa, Olivia Young, Biddut DebNath, Sudershan R. Gondi, Rajiv Rangan, Dorette Z. Ellis, Gulab Zode, Dorota L. Stankowska, and Suchismita Acharya
- Subjects
trabecular meshwork ,mitochondria ,oxygen consumption rate ,extracellular acidification rate ,small molecules ,antioxidants ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Oxidative stress (OS)-induced mitochondrial damage is a risk factor for primary open-angle glaucoma (POAG). Mitochondria-targeted novel antioxidant therapies could unearth promising drug candidates for the management of POAG. Previously, our dual-acting hybrid molecule SA-2 with nitric oxide-donating and antioxidant activity reduced intraocular pressure and improved aqueous humor outflow in rodent eyes. Here, we examined the mechanistic role of SA-2 in trabecular meshwork (TM) cells in vitro and measured the activity of intracellular antioxidant enzymes during OS. Primary human TM cells isolated from normal (hNTM) or glaucomatous (hGTM) post-mortem donors and transformed glaucomatous TM cells (GTM-3) were used for in vitro assays. We examined the effect of SA-2 on oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in vitro using Seahorse Analyzer with or without the oxidant, tert-butyl hydroperoxide (TBHP) treatment. Concentrations of total antioxidant enzymes, catalase (CAT), malondialdehyde (MDA), and glutathione peroxidase (GPx) were measured. We observed significant protection of both hNTM and hGTM cells from TBHP-induced cell death by SA-2. Antioxidant enzymes were elevated in SA-2-treated cells compared to TBHP-treated cells. In addition, SA-2 demonstrated an increase in mitochondrial metabolic parameters. Altogether, SA-2 protected both normal and glaucomatous TM cells from OS via increasing mitochondrial energy parameters and the activity of antioxidant enzymes.
- Published
- 2023
- Full Text
- View/download PDF
27. Building Team Medicine in the Management of CNS Metastases
- Author
-
Archit B. Baskaran, Robin A. Buerki, Osaama H. Khan, Vinai Gondi, Roger Stupp, Rimas V. Lukas, and Victoria M. Villaflor
- Subjects
brain metastases ,delivery of health care ,leptomeningeal metastases ,tumor board ,Medicine - Abstract
CNS metastases are often terminal for cancer patients and occur at an approximately 10-fold higher rate than primary CNS tumors. The incidence of these tumors is approximately 70,000–400,000 cases annually in the US. Advances that have occurred over the past two decades have led to more personalized treatment approaches. Newer surgical and radiation techniques, as well as targeted and immune therapies, have enanled patient to live longer, thus increasing the risk for the development of CNS, brain, and leptomeningeal metastases (BM and LM). Patients who develop CNS metastases have often been heavily treated, and options for future treatment could best be addressed by multidisciplinary teams. Studies have indicated that patients with brain metastases have improved survival outcomes when cared for in high-volume academic institutions using multidisciplinary teams. This manuscript discusses a multidisciplinary approach for both parenchymal brain metastases as well as leptomeningeal metastases implemented in three academic institutions. Additionally, with the increasing development of healthcare systems, we discuss optimizing the management of CNS metastases across healthcare systems and integrating basic and translational science into our clinical care to further improve outcomes. This paper summarizes the existing therapeutic approaches to the treatment of BM and LM and discusses novel and emerging approaches to optimizing access to neuro-oncologic care while simultaneously integrating multidisciplinary teams in the care of patients with BM and LM.
- Published
- 2023
- Full Text
- View/download PDF
28. A stochastic oscillator model simulates the entrainment of vertebrate cellular clocks by light
- Author
-
Vojtěch Kumpošt, Daniela Vallone, Srinivas Babu Gondi, Nicholas S. Foulkes, Ralf Mikut, and Lennart Hilbert
- Subjects
Medicine ,Science - Abstract
Abstract The circadian clock is a cellular mechanism that synchronizes various biological processes with respect to the time of the day. While much progress has been made characterizing the molecular mechanisms underlying this clock, it is less clear how external light cues influence the dynamics of the core clock mechanism and thereby entrain it with the light–dark cycle. Zebrafish-derived cell cultures possess clocks that are directly light-entrainable, thus providing an attractive laboratory model for circadian entrainment. Here, we have developed a stochastic oscillator model of the zebrafish circadian clock, which accounts for the core clock negative feedback loop, light input, and the proliferation of single-cell oscillator noise into population-level luminescence recordings. The model accurately predicts the entrainment dynamics observed in bioluminescent clock reporter assays upon exposure to a wide range of lighting conditions. Furthermore, we have applied the model to obtain refitted parameter sets for cell cultures exposed to a variety of pharmacological treatments and predict changes in single-cell oscillator parameters. Our work paves the way for model-based, large-scale screens for genetic or pharmacologically-induced modifications to the entrainment of circadian clock function.
- Published
- 2021
- Full Text
- View/download PDF
29. Translation of the Gothenburg Trismus Questionnaire-2 into Telugu and its Validation for use in Indian Patients
- Author
-
Bhanu Prakash, Bylapudi, Chava, Sravankumar, Gondi, Jonathan T., Rao S, L. M. Chandra Sekara, Finizia, Caterina, Rao, T. Subramanyeshwar, and Nemade, Hemantkumar Onkar
- Published
- 2021
- Full Text
- View/download PDF
30. The Cognitive Effects of Radiotherapy for Brain Metastases
- Author
-
Eric J. Lehrer, Brianna M. Jones, Daniel R. Dickstein, Sheryl Green, Isabelle M. Germano, Joshua D. Palmer, Nadia Laack, Paul D. Brown, Vinai Gondi, Jeffrey S. Wefel, Jason P. Sheehan, and Daniel M. Trifiletti
- Subjects
brain metastases ,cognition ,radiation therapy ,radiosurgery ,whole brain radiation therapy ,neurosurgery ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Brain metastases are the most common intracranial neoplasm and are seen in upwards of 10-30% of patients with cancer. For decades, whole brain radiation therapy (WBRT) was the mainstay of treatment in these patients. While WBRT is associated with excellent rates of intracranial tumor control, studies have demonstrated a lack of survival benefit, and WBRT is associated with higher rates of cognitive deterioration and detrimental effects on quality of life. In recent years, strategies to mitigate this risk, such as the incorporation of memantine and hippocampal avoidance have been employed with improved results. Furthermore, stereotactic radiosurgery (SRS) has emerged as an appealing treatment option over the last decade in the management of brain metastases and is associated with superior cognitive preservation and quality of life when compared to WBRT. This review article evaluates the pathogenesis and impact of cranial irradiation on cognition in patients with brain metastases, as well as current and future risk mitigation techniques.
- Published
- 2022
- Full Text
- View/download PDF
31. Multidisciplinary Management of Isocitrate Dehydrogenase–Mutated Gliomas in a Contemporary Molecularly Defined Era.
- Author
-
Kotecha, Rupesh, Schiff, David, Chakravarti, Arnab, Fleming, Jessica L., Brown, Paul D., Puduvalli, Vinay K., Vogelbaum, Michael A., Gondi, Vinai, Gallus, Marco, Okada, Hideho, and Mehta, Minesh P.
- Published
- 2024
- Full Text
- View/download PDF
32. Longitudinal Change and Predictors of Myocardial Flow Reserve by Positron Emission Tomography for the Evaluation of Cardiac Allograft Vasculopathy Following Heart Transplantation.
- Author
-
Gondi, Keerthi T., Hammer, Yoav, Yosef, Matheos, Golbus, Jessica R., Madamanchi, Chaitanya, Aaronson, Keith D., Murthy, Venkatesh L., and Konerman, Matthew C.
- Abstract
• Myocardial flow reserve (MFR) on positron emission tomography longitudinally declines over time after heart transplantation and is prognostic for adverse post-transplant events. • Cardiometabolic risk factors, allograft rejection and cytomegalovirus infection are associated with reduced MFR and, therefore, the development and progression of cardiac allograft vasculopathy. • The use of moderate- to high-intensity statin therapy is associated with a higher MFR, and escalation of statin intensity may reduce the incidence of cardiac allograft vasculopathy. Positron emission tomography (PET) myocardial flow reserve (MFR) is a noninvasive method of detecting cardiac allograft vasculopathy in recipients of heart transplants (HTs). There are limited data on longitudinal change and predictors of MFR following HT. We conducted a retrospective analysis of HT recipients undergoing PET myocardial perfusion imaging at an academic center. Multivariable linear and Cox regression models were constructed to identify longitudinal trends, predictors and the prognostic value of MFR after HT. Of HT recipients, 183 underwent 658 PET studies. The average MFR was 2.34 ± 0.70. MFR initially increased during the first 3 years following HT (+ 0.12 per year; P = 0.01) before beginning to decline at an annual rate of -0.06 per year (P < 0.001). MFR declines preceding acute rejection and improves after treatment. Treatment with mammalian target of rapamycin (mTOR) inhibitors (37.2%) slowed the rate of annual MFR decline (P = 0.03). Higher-intensity statin therapy was associated with improved MFR. Longer time post-transplant (P < 0.001), hypertension (P < 0.001), chronic kidney disease (P < 0.001), diabetes mellitus (P = 0.038), antibody-mediated rejection (P = 0.040), and cytomegalovirus infection (P = 0.034) were associated with reduced MFR. Reduced MFR (HR: 7.6, 95% CI: 4.4–13.4; P < 0.001) and PET-defined ischemia (HR: 2.3, 95% CI: 1.4–3.9; P < 0.001) were associated with a higher risk of the composite outcome of mortality, retransplantation, heart failure hospitalization, acute coronary syndrome, or revascularization. MFR declines after the third post-transplant year and is prognostic for cardiovascular events. Cardiometabolic risk-factor modification and treatment with higher-intensity statin therapy and mechanistic target of rapamycin inhibitors are associated with a higher MFR. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer
- Author
-
N. Patrik Brodin, Rafi Kabarriti, Clyde B. Schechter, Mark Pankuch, Vinai Gondi, Shalom Kalnicki, Madhur K. Garg, and Wolfgang A. Tomé
- Subjects
Proton therapy ,Quality of life ,Cost-effectiveness ,Individualized risk-assessment ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Proton therapy is a promising advancement in radiation oncology especially in terms of reducing normal tissue toxicity, although it is currently expensive and of limited availability. Here we estimated the individual quality of life benefit and cost-effectiveness of proton therapy in patients with oropharyngeal cancer treated with definitive radiation therapy (RT), as a decision-making tool for treatment individualization. Methods and materials Normal tissue complication probability models were used to estimate the risk of dysphagia, esophagitis, hypothyroidism, xerostomia and oral mucositis for 33 patients, comparing delivered photon intensity-modulated RT (IMRT) plans to intensity-modulated proton therapy (IMPT) plans. Quality-adjusted life years (QALYs) lost were calculated for each complication while accounting for patient-specific conditional survival probability and assigning quality-adjustment factors based on complication severity. Cost-effectiveness was modeled based on upfront costs of IMPT and IMRT, and the cost of acute and/or long-term management of treatment complications. Uncertainties in all model parameters and sensitivity analyses were included through Monte Carlo sampling. Results The incremental cost-effectiveness ratios (ICERs) showed considerable variability in the cost of QALYs spared between patients, with median $361,405/QALY for all patients, varying from $54,477/QALY to $1,508,845/QALY between individual patients. Proton therapy was more likely to be cost-effective for patients with p16-positive tumors ($234,201/QALY), compared to p16-negative tumors ($516,297/QALY). For patients with p16-positive tumors treated with comprehensive nodal irradiation, proton therapy is estimated to be cost-effective in ≥ 50% of sampled cases for 8/9 patients at $500,000/QALY, compared to 6/24 patients who either have p16-negative tumors or receive unilateral neck irradiation. Conclusions Proton therapy cost-effectiveness varies greatly among oropharyngeal cancer patients, and highlights the importance of individualized decision-making. Although the upfront cost, societal willingness to pay and healthcare administration can vary greatly among different countries, identifying patients for whom proton therapy will have the greatest benefit can optimize resource allocation and inform prospective clinical trial design.
- Published
- 2021
- Full Text
- View/download PDF
34. Pathological Features of Lung in COVID-19 Disease Subjects: A Postmortem Study
- Author
-
Bhanu Rekha Bokam, Chetana Gondi, and Revanth Kumar Nakka
- Subjects
acute lung injury ,core needle biopsy ,coronavirus disease-2019 ,Medicine - Abstract
Introduction: The current Coronavirus Disease-19 (COVID-19) pandemic is considered as one of the most serious public health crises which caused more than 1.62 million deaths from October 2020 to November 2020. Acute respiratory failure is leading cause of death followed by sepsis, cardiac failure and haemorrhage. Since the pathological findings are diverse in COVID-19 and majority of studies in literature were by open autopsy; the present study was done using percutaneous core needle biopsy. Postmortem lung biopsies are rather easy and quick to perform and decrease the infective risk caused by full autopsies. This could be an essential tool for diagnosis, surveillance and research. Aim: To study the pathological features of lung in COVID-19 deceased patients by postmortem. Materials and Methods: This cross-sectional study was conducted in the Department of Pulmonary Medicine, Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Vijayawada, Andhra Pradesh, India from October 2020 to November 2020. In present study, postmortem percutaneous core needle biopsies from lung were performed within two hours of death from eight deceased patients who died of COVID-19. Clinical history, inflammatory markers and treatment details were collected from case sheets, biopsy was done, specimen was collected and sent for pathological examination. Data was presented in the descriptive form for each variable. Results: Out of eight cases, five were men and three were women with a mean age of 54.12 years. Majority of patients presented with complaints of shortness of breath and fever. Hypertension, type 2 diabetes mellitus, obesity, hypothyroidism, history of pulmonary tuberculosis were the co-morbidities noticed. Four biopsies presented acute lung injury with hyaline membrane changes, Diffuse Alveolar Damage (DAD) with hyaline membrane was seen in two cases, squamous metaplasia was seen in two cases and acute lung injury with organising pneumonia was seen in two cases. Conclusion: Postmortem lung biopsies are safe, easy to perform and provide insights of possible undergoing pathology of the disease with regard to clinical presentation.
- Published
- 2022
- Full Text
- View/download PDF
35. Self-offloading therapeutic footwear using compliant snap-through arches
- Author
-
Priyabrata Maharana, Jyoti Sonawane, Pavan Belehalli, and Gondi Kondaiah Ananthasuresh
- Subjects
critical dynamic force ,offloading ,plantar pressure ,snap-through ,switchback time ,Mechanical engineering and machinery ,TJ1-1570 ,Electronics ,TK7800-8360 - Abstract
In diabetic peripheral neuropathy, offloading high-plantar-pressure areas using statically offloaded customized insoles or expensive sensors and actuators are commonly-followed treatment procedures. In this article, we propose the concept of dynamically self-offloading therapeutic footwear that operates mechanically without using sensors and actuators. We achieve this by using an array of snapping arches. When a load higher than a bespoke value is applied, these arches enter negative-stiffness regime and offload the high-pressure region by snapping to a different shape. They again return to their initial shape when the load disappears. Thus, they serve as both sensors and actuators that get actuated by person’s body weight. We present an analytical method to compute the switching load and the switchback time of such arches and use them to customize the footwear according to the person’s body weight, gait speed, and foot size. We identify the high-pressure regions from the clinical data and place the arches such that these high-pressure regions get dynamically offloaded, and the pressure gets redistributed to other regions. We considered 200 kPa as a limiting pressure to prevent the prolonged effects of high plantar pressure. To check the efficacy of the concept, a complete 3D-printed prototype made of thermoplastic polyurethane was tested and compared with barefoot and in-shoe plantar pressure for subjects recruited at a clinical facility. We notice that the self-offloading insole shows the plantar pressure reduction at all the foot regions, and significant offloading of 57% is observed at the forefoot region.
- Published
- 2022
- Full Text
- View/download PDF
36. A pilot phase Ib/II study of whole-lung low dose radiation therapy (LDRT) for the treatment of severe COVID-19 pneumonia: First experience from Africa.
- Author
-
Mansoor Saleh, Karishma Sharma, Jasmit Shah, Farrok Karsan, Angela Waweru, Martin Musumbi, Reena Shah, Shahin Sayed, Innocent Abayo, Noureen Karimi, Stacey Gondi, Sehrish Rupani, Grace Kirathe, and Heldah Amariati
- Subjects
Medicine ,Science - Abstract
BackgroundLow dose radiation therapy (LDRT) has been used for non-malignant conditions since early 1900s based on the ability of single fractions between 50-150 cGy to inhibit cellular proliferation. Given scarcity of resources, poor access to vaccines and medical therapies within low and middle income countries, there is an urgent need to identify other cost-effective alternatives in management of COVID-19 pneumonia. We conducted a pilot phase Ib/II investigator-initiated clinical trial to assess the safety, feasibility, and toxicity of LDRT in patients with severe COVID-19 pneumonia at the Aga Khan University Hospital in Nairobi, Kenya. Additionally, we also assessed clinical benefit in terms of improvement in oxygenation at day 3 following LDRT and the ability to avoid mechanical ventilation at day 7 post LDRT.MethodsPatients with both polymerase chain reaction (PCR) and high-resolution computer tomogram (HRCT) confirmed severe COVID-19 pneumonia, not improving on conventional therapy including Dexamethasone and with increasing oxygen requirement were enrolled in the study. Patients on mechanical ventilation were excluded. Eligible patients received a single 100cGy fraction to the whole lung. In the absence of any dose limiting toxicity the study proposed to treat a total of 10 patients. The primary endpoints were to assess the safety/feasibility, and toxicity within the first 24 hours post LDRT. The secondary endpoints were to assess efficacy of LDRT at Day 3, 7, 14 and 28 post LDRT.ResultsTen patients were treated with LDRT. All (100%) of patients were able to complete LDRT without treatment related SAE within the first 24 hours post treatment. None of the patients treated with LDRT experienced any acute toxicity as defined by change in clinical and respiratory status at 24hr following LDRT. Majority (90%) of patients avoided mechanical ventilation within 7 days of LDRT. Four patients (40%) demonstrated at least 25% improvement in oxygen requirements within 3 days. Six patients (60%) were discharged and remained off oxygen, whereas four progressed and died (1 due to sepsis and 3 in cytokine storm). Median time to discharge (n = 6) was 16.5 days and median time to death (n = 4) was 11.0 days. Patients who ultimately died showed elevated inflammatory markers including Ferritin, CRP and D-dimers as compared to those who were discharged alive.ConclusionLDRT was feasible, safe and shows promise in the management of severe COVID-19 pneumonia including in patients progressing on conventional systemic treatment. Additional phase II trials are warranted to identify patients most likely to benefit from LDRT.
- Published
- 2022
- Full Text
- View/download PDF
37. Amelioration of Biogas Production from Waste-Activated Sludge through Surfactant-Coupled Mechanical Disintegration
- Author
-
Vijetha Valsa, Geethu Krishnan S, Rashmi Gondi, Preethi Muthu, Kavitha Sankarapandian, Gopalakrishnan Kumar, Poornachandar Gugulothu, and Rajesh Banu Jeyakumar
- Subjects
solubilization ,paper mill sludge ,suspended solids ,disperser ,specific energy input ,Fermentation industries. Beverages. Alcohol ,TP500-660 - Abstract
The current study intended to improve the disintegration potential of paper mill sludge through alkyl polyglycoside-coupled disperser disintegration. The sludge biomass was fed to the disperser disintegration and a maximum solubilization of 6% was attained at the specific energy input of 4729.24 kJ/kg TS. Solubilization was further enhanced by coupling the optimum disperser condition with varying dosage of alkyl polyglycoside. The maximum solubilization of 11% and suspended solid (SS) reduction of 8.42% were achieved at the disperser rpm, time, and surfactant dosage of 12,000, 30 min, and 12 μL. The alkyl polyglycoside-coupled disperser disintegration showed a higher biogas production of 125.1 mL/gCOD, compared to the disperser-alone disintegration (70.1 mL/gCOD) and control (36.1 mL/gCOD).
- Published
- 2023
- Full Text
- View/download PDF
38. Synergistic Effect of Surfactant on Disperser Energy and Liquefaction Potential of Macroalgae (Ulva intestinalis) for Biofuel Production
- Author
-
Rinsha Puthiya Veettil, Rabia, Dinesh Kumar Mathew, Rashmi Gondi, Kavitha Sankarapandian, Meganathan Kannan, Gopalakrishnan Kumar, Siham Y. Al-Qaradawi, and Rajesh Banu Jeyakumar
- Subjects
Ulva intestinalis ,disperser ,surfactant ,liquefaction ,methane ,Fermentation industries. Beverages. Alcohol ,TP500-660 - Abstract
The objective of this study was to evaluate the effect of surfactant on disperser homogenization pretreatment for macroalgae (Ulva intestinalis) to enhance biogas production. The macroalgae are subjected to surfactant coupled disperser pretreatment, which enhanced the liquefaction and improved the biomethane production. The outcome of this study revealed that 10,000 rpm at 20 min with a specific energy input of 1748.352 kJ/ kg total solids (TS) are the optimum conditions for surfactant disperser pretreatment (SDP), which resulted in the liquefaction rate of 20.08% with soluble organics release of 1215 mg/L and showed a better result than disperser pretreatment (DP) with a liquefaction rate of 14%. Biomethane production through the SDP method was found to be 0.2 g chemical oxygen demand (COD)/g COD, which was higher than DP (0.11 g COD/g COD). SDP was identified to be a synergetic pretreatment method with an energy ratio and net profit of about 0.91 and 104.04 United States dollars (USD)/ton, respectively.
- Published
- 2023
- Full Text
- View/download PDF
39. Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer
- Author
-
Brodin, N. Patrik, Kabarriti, Rafi, Schechter, Clyde B., Pankuch, Mark, Gondi, Vinai, Kalnicki, Shalom, Garg, Madhur K., and Tomé, Wolfgang A.
- Published
- 2021
- Full Text
- View/download PDF
40. A stochastic oscillator model simulates the entrainment of vertebrate cellular clocks by light
- Author
-
Kumpošt, Vojtěch, Vallone, Daniela, Gondi, Srinivas Babu, Foulkes, Nicholas S., Mikut, Ralf, and Hilbert, Lennart
- Published
- 2021
- Full Text
- View/download PDF
41. Effect of Erosive Challenges on Microhardness of Three Different Nanocomposites: An In-vitro Study
- Author
-
POREDDY SATHYANARAYANA REDDY, GONDI DURGA BHAVANI, KASAMSETTY ARCHANA GUPTA, VITTA HARISH MADHAV, DIVYA JAHAGIRDAR, and SRIDHAR REDDY ERUGULA
- Subjects
ceram x mono ,filtek ,hydrochloric acid ,tetric n ceram ,Medicine - Abstract
Introduction: The loss of tooth structure in natural tooth can be attributed to several aetiological factors like dental caries, traumatic injuries and non carious lesions like attrition, abrasion, erosion. All the lesions result in loss of enamel and dentin which eventually need to be replaced with restorative materials. Aim: To evaluate the effect of different acidic solutions on the surface microhardness of three different nanocomposite restorative materials after one day and six weeks time interval. Materials and Methods: The present in-vitro study comprised of three different composite resin materials, Filtek Z 350 (3M ESPE, St. Paul, USA), Ceram X Mono (Dentsply, Konstanz, India) and Tetric N Ceram (Ivoclar Vivadent, Schaan, Liechtenstein). Twenty four samples were divided into three groups. Group I: Eight specimens of each restorative material were immersed individually in 10 mL of artificial saliva. Group II: Eight specimens of each restorative material were immersed in artificial saliva for four hours and later immersed for five minutes in a tube containing 10 mL of coca cola under stirring and later stored in artificial saliva. This process was repeated for three times a day. Group III: Eight specimens of each test material were individually immersed in artificial saliva for four hours and later immersed in 10 mL of hydrochloric acid (HCl) for five minutes under stirring and later stored in artificial saliva. This process was done three times a day. Vicker’s diamond indenter was used to test the microhardness. Paired t-test, independent t-test, one-way Analysis of Variance (one-way ANOVA) and post hoc test were used for analysis. Results: There was no significant statistical difference (p-value >0.05) in the surface microhardness between all the tested solutions after day 1 time period of Filtek Z 350. There was significant difference of the surface microhardness between all the groups in all the solutions except for Filtek Z 350 and Ceram X Mono in HCl solution at 6 weeks. Conclusion: There was statistically significant reduction in surface microhardness of the three composites immersed in all the three solutions of artificial saliva, coca cola and hydrochloric acid after day 1 and six weeks time interval.
- Published
- 2021
- Full Text
- View/download PDF
42. Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic
- Author
-
Jennifer K. Matsui, Haley K. Perlow, Cyril Baiyee, Alex R. Ritter, Mark V. Mishra, Joseph A. Bovi, Vinai Gondi, Paul D. Brown, Ashlee R. Loughan, Heather E. Leeper, Erica Dawson, and Joshua D. Palmer
- Subjects
brain metastases ,radiotherapy ,quality of life ,cognition ,cognitive function ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Brain metastases (BMs) account for a disproportionately high percentage of cancer morbidity and mortality. Historically, studies have focused on improving survival outcomes, and recent radiation oncology clinical trials have incorporated HRQOL and cognitive assessments. We are now equipped with a battery of assessments in the radiation oncology clinic, but there is a lack of consensus regarding how to incorporate them in modern clinical practice. Herein, we present validated assessments for BM patients, current recommendations for future clinical studies, and treatment advances that have improved HRQOL and cognitive outcomes for BM patients.
- Published
- 2022
- Full Text
- View/download PDF
43. Immunotherapy and Radiotherapy Combinations for Sarcoma.
- Author
-
Zhang, Qian S., Hayes, John P., Gondi, Vinai, and Pollack, Seth M.
- Abstract
Sarcomas are a heterogeneous group of bone and soft tissue tumors. Survival outcomes for advanced (unresectable or metastatic) disease remain poor, so therapeutic improvements are needed. Radiotherapy plays an integral role in the neoadjuvant and adjuvant treatment of localized disease as well as in the treatment of metastatic disease. Combining radiotherapy with immunotherapy to potentiate immunotherapy has been used in a variety of cancers other than sarcoma, and there is opportunity to further investigate combining immunotherapy with radiotherapy to try to improve outcomes in sarcoma. In this review, we describe the diversity of the tumor immune microenvironments for sarcomas and describe the immunomodulatory effects of radiotherapy. We discuss studies on the timing of radiotherapy relative to immunotherapy and studies on the radiotherapy dose and fractionation regimen to be used in combination with immunotherapy. We describe the impact of radiotherapy on the tumor immune microenvironment. We review completed and ongoing clinical trials combining radiotherapy with immunotherapy for sarcoma and propose future directions for studies combining immunotherapy with radiotherapy in the treatment of sarcoma. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933
- Author
-
Joseph A. Bovi, MD, Stephanie L. Pugh, PhD, David Sabsevitz, PhD, Clifford G. Robinson, MD, Eric Paulson, PhD, Minesh P. Mehta, MD, Vinai Gondi, MD, Vijayananda Kundapur, MD, Mark S. Shahin, MD, Samuel T. Chao, MD, Mitch Machtay, MD, Albert S. DeNittis, MD, Nadia N. Laack, MD, Jeffrey N. Greenspoon, MD, Kathleen N. Moore, MD, Jiayi Huang, MD, Michael M. Dominello, DO, and Lisa A. Kachnic, MD
- Subjects
Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Purpose: NRG Oncology's RTOG 0933 demonstrated benefits to memory preservation after hippocampal avoidant whole-brain radiation therapy (HA-WBRT), the avoidance of radiation dose to the hippocampus (using intensity modulated radiation planning and delivery techniques) during WBRT, supporting the hypothesis of hippocampal radiosensitivity and associated memory specificity. However, some patients demonstrated cognitive decline, suggesting mechanisms outside hippocampal radiosensitivity play a role. White matter injury (WMI) has been implicated in radiation therapy–induced neurocognitive decline. This secondary analysis explored the relationship between pretreatment WMI and memory after HA-WBRT. Methods and Materials: Volumetric analysis of metastatic disease burden and disease-unrelated WMI was conducted on the pretreatment magnetic resonance image. Correlational analyses were performed examining the relationship between pretreatment WMI and Hopkins Verbal Learning Test-Revised (HVLT-R) outcomes at baseline and 4 months after HA-WBRT. Results: In the study, 113 patients received HA-WBRT. Of 113 patients, 33 underwent pretreatment and 4-month posttreatment HVLT testing and pretreatment postcontrast volumetric T1 and axial T2/fluid-attenuated inversion recovery magnetic resonance imaging. Correlation was found between larger volumes of pretreatment WMI and decline in HVLT-R recognition (r = 0.54, P
- Published
- 2019
- Full Text
- View/download PDF
45. Physician perceived barriers and facilitators for self-measured blood pressure monitoring- a qualitative study.
- Author
-
Saahith Gondi, Shellie Ellis, Mallika Gupta, Edward Ellerbeck, Kimber Richter, Jeffrey Burns, and Aditi Gupta
- Subjects
Medicine ,Science - Abstract
IntroductionImproving hypertension management is a national priority that can decrease morbidity and mortality. Evidence-based hypertension management guidelines advocate self-measured BP (SMBP), but widespread implementation of SMBP is lacking. The purpose of this study was to describe the perspective of primary care physicians (PCPs) on SMBP to identify the barriers and facilitators for implementing SMBP.MethodsWe collected data from PCPs from a large health system using semi-structured interviews based on the Theoretical Domains Framework (TDF). Responses were recorded, transcribed, and qualitatively analyzed into three overarching TDF domains based on the Behavior Change Wheel (BCW): 1) Motivation 2) Opportunity and 3) Capabilities. The sample size was based on theme saturation.ResultsAll 17 participating PCPs believed that SMBP is a useful, but underutilized tool. Although individual practices varied, most physicians felt that the increased data points from SMBP allowed for better hypertension management. Most felt that overcoming existing barriers would be difficult, but identified several facilitators: physician support of SMBP, the possibility of having other trained health professionals to assist with SMBP and patient education; improving patient engagement and empowerment with SMBP, and the interest of the health system in using technology to improve hypertension management.ConclusionPCPs believe that SMBP can improve hypertension management. There are numerous barriers and facilitators for implementing SMBP. Successful implementation in clinical practice will require implementation strategies targeted at increasing patient acceptability and reducing physician workload. This may need a radical change in the current methods of managing hypertension.
- Published
- 2021
- Full Text
- View/download PDF
46. The Story of #GetMePPE and GetUsPPE.org to Mobilize Health Care Response to COVID-19 : Rapidly Deploying Digital Tools for Better Health Care
- Author
-
He, Shuhan, Ojo, Ayotomiwa, Beckman, Adam L, Gondi, Suhas, Betz, Marian, Faust, Jeremy S, Choo, Esther, Kass, Dara, and Raja, Ali S
- Subjects
Computer applications to medicine. Medical informatics ,R858-859.7 ,Public aspects of medicine ,RA1-1270 - Abstract
Physicians, nurses, and other health care providers initiated the #GetMePPE movement on Twitter to spread awareness of the shortage of personal protective equipment (PPE) during the coronavirus disease (COVID-19) pandemic. Dwindling supplies, such as face masks, gowns and goggles, and inadequate production to meet increasing demand have placed health care workers and patients at risk. The momentum of the #GetMePPE Twitter hashtag resulted in the creation of a petition to urge public officials to address the PPE shortage through increased funding and production. Simultaneously, the GetUsPPE.org website was launched through the collaboration of physicians and software engineers to develop a digital platform for the donation, request, and distribution of multi-modal sources of PPE. GetUsPPE.org and #GetMePPE were merged in an attempt to combine public engagement and advocacy on social media with the coordination of PPE donation and distribution. Within 10 days, over 1800 hospitals and PPE suppliers were registered in a database that enabled the rapid coordination and distribution of scarce and in-demand materials. One month after its launch, the organization had distributed hundreds of thousands of PPE items and had built a database of over 6000 PPE requesters. The call for action on social media and the rapid development of this digital tool created a productive channel for the public to contribute to the health care response to COVID-19 in meaningful ways. #GetMePPE and GetUsPPE.org were able to mobilize individuals and organizations outside of the health care system to address the unmet needs of the medical community. The success of GetUsPPE.org demonstrates the potential of digital tools as a platform for larger health care institutions to rapidly address urgent issues in health care. In this paper, we outline this process and discuss key factors determining success.
- Published
- 2020
- Full Text
- View/download PDF
47. Correction to: Translation of the Gothenburg Trismus Questionnaire‑2 into Telugu and its Validation for use in Indian Patients
- Author
-
Prakash, Bylapudi Bhanu, Chava, Sravankumar, Gondi, Jonathan T., Chandra Sekara Rao S, L. M., Finizia, Caterina, Rao, T. Subramanyeshwar, and Nemade, Hemantkumar Onkar
- Published
- 2021
- Full Text
- View/download PDF
48. Host-mediated selection impacts the diversity of Plasmodium falciparum antigens within infections
- Author
-
Angela M. Early, Marc Lievens, Bronwyn L. MacInnis, Christian F. Ockenhouse, Sarah K. Volkman, Samuel Adjei, Tsiri Agbenyega, Daniel Ansong, Stacey Gondi, Brian Greenwood, Mary Hamel, Chris Odero, Kephas Otieno, Walter Otieno, Seth Owusu-Agyei, Kwaku Poku Asante, Hermann Sorgho, Lucas Tina, Halidou Tinto, Innocent Valea, Dyann F. Wirth, and Daniel E. Neafsey
- Subjects
Science - Abstract
Host immune responses exert selective pressure on Plasmodium falciparum. Here, the authors show that allele-specific immunity impacts the antigenic diversity of individual malaria infections. This process partially explains the extreme amino acid diversity of many parasite antigens and suggests that vaccines should account for allele-specific immunity.
- Published
- 2018
- Full Text
- View/download PDF
49. Cardiac rehabilitation after percutaneous coronary intervention – Evidence and barriers
- Author
-
Naga Venkata K Pothineni, Suhas Gondi, and Swathi Kovelamudi
- Subjects
cardiac rehabilitation ,health policy ,percutaneous coronary intervention ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Cardiac rehabilitation (CR) represents a spectrum of interventions that influence physical, mental, and social well-being of an individual. These interventions can range from dietary counseling to intense physical activity. The role of CR in various cardiac disorders, particularly ischemic heart disease, has been well established across multiple studies. However, real-world utilization of CR still seems to lag behind. As coronary intervention modalities keep evolving with increasing number of patients receiving percutaneous coronary intervention, there is a need for reappraisal of the role of CR in this population. In this review, we discuss data behind the benefit of CR in patients with ischemic heart disease and highlight the barriers encountered in implementing CR in real-world practice.
- Published
- 2018
- Full Text
- View/download PDF
50. Publisher Correction: Green Synthesis of Substituted Anilines and Quinazolines from Isatoic Anhydride-8-amide
- Author
-
Gondi, Sudershan R., Bera, Asim K., and Westover, Kenneth D.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.